EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 25-Jun-2026 12:15 ET (25-Jun-2026 16:15 GMT/UTC)

Awareness of alcohol-cancer link holds steady despite omission from new US dietary guidelines

Annenberg Public Policy Center of the University of Pennsylvania
Reports and Proceedings

A new Annenberg survey finds that the public's awareness of the link between alcohol consumption and cancer risk remains steady.

Colorectal cancer risk with negative colonoscopy or nonadherence after positive fecal occult blood test screening

JAMA Network
Peer-Reviewed Publication

About The Study: In this study, a decrease in colorectal cancer (CRC) incidence was observed among individuals with negative results in screening colonoscopies, with a greater decrease in men, supporting risk-based, individualized follow-up strategies. A high-risk group for CRC was identified among individuals who did not adhere to follow-up colonoscopy, enabling targeted interventions to improve early CRC detection.

Journal: JAMA Network Open

Tumor-informed liquid biopsy suggests structural-variant ddPCR can monitor high-grade serous ovarian cancer

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — March 19, 2026 — A new research paper was published in Volume 13 of Oncoscience on March 5, 2026, titled “Tumor-informed liquid biopsy detection of structural variants in high grade serous ovarian cancer.”

Journal: Oncoscience

ECOG-ACRIN completes enrollment for 600-patient clinical trial focused on frontline therapy for advanced melanoma

ECOG-ACRIN Cancer Research Group
Business Announcement

A large cancer clinical trial is investigating whether adding sargramostim, an immunomodulatory cytokine, to dual immunotherapy consisting of nivolumab and ipilimumab can improve outcomes for patients with metastatic melanoma. It builds earlier evidence suggesting this approach may enhance survival while reducing toxicity. Patient follow-up is ongoing.

Blood test may improve survival of childhood cancer in Africa

University of Oxford
Peer-Reviewed Publication

A simple blood test could speed up diagnosis and improve outcomes for children with Africa’s most common childhood cancer.

Journal: Nature Medicine

Small shrinking organ may prove decisive for life or death

Aarhus University
Peer-Reviewed Publication

Researchers at Aarhus University are reshaping our understanding of the immune system: a small organ, long believed to cease functioning early in adult life, plays a lifelong role in the risk of cancer and cardiovascular disease – and in determining whether modern cancer treatments are effective.

Journal: Nature
Funder: Novo Nordisk Fonden

HKUST researchers achieve breakthrough in RNA silencing mechanism

Hong Kong University of Science and Technology
Peer-Reviewed Publication

A research team from The Hong Kong University of Science and Technology (HKUST) has made a breakthrough discovery in understanding the molecular machinery of RNA silencing. The team uncovered how the human enzyme DICER achieves highly precise processing of microRNAs (miRNAs), advancing gene regulation research and offering new insights into the mechanisms underlying cancer, immune disorders, and genetic diseases.

Journal: Nature

Researchers make breakthrough in biomedical imaging and cancer treatment

Fundação de Amparo à Pesquisa do Estado de São Paulo
Peer-Reviewed Publication

A group from the University of São Paulo transformed hydroxyapatite, a bioceramic material, into a nanoparticle with enhanced intrinsic luminescence.

Journal: ACS Nanoscience Au
Funder: Fundação de Amparo à Pesquisa do Estado de São Paulo

MSU scientists uncover how HPV-positive cancers hide from the immune system — and how to make them visible again

Michigan State University College of Human Medicine
Peer-Reviewed Publication

A team of scientists have uncovered a mechanism that allows certain head and neck cancers to hide from the immune system, a discovery that could change how some of the most treatment resistant tumors are approached. The study, published in Proceedings of the National Academy of Sciences identifies a single protein at the heart of this invisibility and shows that removing it can make hidden tumors vulnerable to treatment.

Journal: Proceedings of the National Academy of Sciences

Mount Sinai study identifies inflammatory immune pathway driving immunotherapy resistance in bladder cancer

The Mount Sinai Hospital / Mount Sinai School of Medicine
Peer-Reviewed Publication

Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps explain why some bladder cancers do not respond well to immunotherapy. Their findings, published in Cancer Discovery (10.1158/2159-8290.CD-25-1774), show that common signs of inflammation in the blood are linked to immune cells inside tumors that block the body’s ability to fight cancer.

Journal: Cancer Discovery